"Glioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
Descriptor ID |
D005910
|
MeSH Number(s) |
C04.557.465.625.600.380 C04.557.470.670.380 C04.557.580.625.600.380
|
Concept/Terms |
Glioma- Glioma
- Gliomas
- Glial Cell Tumors
- Glial Cell Tumor
- Tumor, Glial Cell
- Tumors, Glial Cell
Mixed Glioma- Mixed Glioma
- Glioma, Mixed
- Gliomas, Mixed
- Mixed Gliomas
Malignant Glioma- Malignant Glioma
- Glioma, Malignant
- Gliomas, Malignant
- Malignant Gliomas
|
Below are MeSH descriptors whose meaning is more general than "Glioma".
Below are MeSH descriptors whose meaning is more specific than "Glioma".
This graph shows the total number of publications written about "Glioma" by people in this website by year, and whether "Glioma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
2005 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 1 | 2 |
2017 | 41 | 3 | 44 |
2018 | 44 | 5 | 49 |
2019 | 9 | 2 | 11 |
2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Glioma" by people in Profiles.
-
Call of duty: neuro-oncology outpatient management during the COVID-19 pandemic in Milan, Italy. Neuro Oncol. 2020 12 18; 22(12):1891-1892.
-
Reply to: "Call of duty: neuro-oncology outpatient management during the COVID-19 pandemic in Milan, Italy". Neuro Oncol. 2020 12 18; 22(12):1893.
-
Treatment of patients with glioma during the COVID-19 pandemic: what we learned and what we take home for the future. Neurosurg Focus. 2020 12; 49(6):E10.
-
The provision of neuro-oncology and glioma neurosurgery during the SARS-CoV-2 pandemic: a single national tertiary centre experience. Ir J Med Sci. 2021 Aug; 190(3):905-911.
-
Awake craniotomy in the COVID-19 era - technical tips and feasibility. J Clin Neurosci. 2020 Dec; 82(Pt A):49-51.
-
Overview of prognostic factors in adult gliomas. Ann Palliat Med. 2021 Jan; 10(1):863-874.
-
Letter to the Editor Re: Mohile et al. Neuro Oncol. 2020 07 07; 22(7):1048-1049.
-
H3K27M-mutant diffuse midline glioma with extensive intratumoral microthrombi in a young adult with COVID-19-associated coagulopathy. Acta Neuropathol. 2020 08; 140(2):227-229.
-
Can COVID-19 induce glioma tumorogenesis through binding cell receptors? Med Hypotheses. 2020 Nov; 144:110009.
-
Natura non facit saltus: a phase 2 proposal to manage brain tumors cases from the Neuro-oncology section of the Italian Society of Neurosurgery (SINch®). J Neurosurg Sci. 2021 Feb; 65(1):1-7.